AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on June 9, 2009
doi: 10.3174/ajnr.A1652

This Article
Free to Access This article has been Unlocked
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Online Tables
Right arrow All Versions of this Article:
ajnr.A1652v1
30/8/1610    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Foerster, B.R.
Right arrow Articles by Schwarz, K.B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foerster, B.R.
Right arrow Articles by Schwarz, K.B.

PEDIATRICS

Minimal Hepatic Encephalopathy in Children: Evaluation with Proton MR Spectroscopy

B.R. Foerstera, L.S. Conklinb, M. Petroua, P.B. Barkera and K.B. Schwarzb

aFrom the Russell H. Morgan Department of Radiology and Radiological Science (B.R.F., M.P., P.B.B.)
bDepartment of Pediatrics (L.S.C., K.B.S.), Johns Hopkins University School of Medicine, Baltimore, Md.

Please address correspondence to Bradley Foerster, MD, Division of Neuroradiology, MRI 143C, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287; e-mail: bfoerst1{at}jhmi.edu

BACKGROUND AND PURPOSE: Minimal hepatic encephalopathy (MHE) in children is difficult to evaluate because of lack of standardized neuropsychological tests for all age ranges. The purpose of this retrospective study of children with clinically suspected MHE was to investigate relationships between brain MR spectroscopy metabolites and biochemical markers of encephalopathy as well as measures of liver disease severity.

MATERIALS AND METHODS: A total of 12 children (age range, 9–19 years; 8 female) with clinically suspected MHE were studied by short TE brain MR spectroscopy on a 1.5T magnet. We estimated gray matter (GM) and white matter (WM) metabolite concentrations using "LCModel" software. Regional metabolite concentrations were examined for correlation with various parameters, including plasma ammonia, the ratio of branched-chain to aromatic amino acids (BCAA/AAA), model for end stage liver disease/pediatric end stage liver disease (MELD/PELD) and Child-Pugh scores, bilirubin, albumin, and platelet counts.

RESULTS: Myo-inositol (mIns) levels correlated with BCAA/AAA ratios (r = 0.86; P = .002 for GM and r = 0.77; P = .01 for WM). WM choline (Cho) levels and GM mIns levels showed significant negative correlation with ammonia levels (r = –0.58; P = .04 and r = –0.65; P = .02, respectively). A positive significant correlation trend was present for GM glutamine/glutamate (Glx) and ammonia levels (r = 0.66; P = .05). There was no correlation of brain MR spectroscopy parameters and severity of liver disease.

CONCLUSIONS: Brain MR spectroscopy metabolites in children with suspected MHE show significant correlations with plasma ammonia levels and BCAA/AAA. As in adults, brain MR spectroscopy in children may be helpful in establishing a diagnosis of MHE.